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HEAD AND NECK REGION HEAD AND NECK CANCER
Lugol chromoendoscopy is the standard method for detecting early squamous cell carcinoma (SCC) of the esophagus. However, Lugol dye solution cannot be applied to the oropharynx or hypopharynx because of the risk of aspiration. Moreover, the image resolution of rhinolaryngoscopy does not effectively identify superficial neoplastic lesions in the head and neck region. Therefore, the early detection of cancers in the oropharynx and hypopharynx has been difficult. This is partly attributable to the technological limitations in mounting a high-resolution CCD on the tip of a rhinolaryngoscope.
Muto et al. first reported the utility of NBI combined with magnifying endoscopy (Q240Z, Olympus Medical Systems, Tokyo, Japan) in the identification of superficial SCCs in the head and neck region (5) . Compared with WLI, NBI significantly improved the visualization of the cancerous lesions by enhancing the contrast between the cancerous lesion and the background nonneoplastic epithelium, and by the clear magnification of the microvascular architecture (6) . Muto et al. reported that the well-demarcated brownish areas observed under NBI and the microvascular 5 irregularities visible under magnification with NBI were useful indicators of cancerous lesions in the head and neck region (1) . In the multicenter prospective randomized study, NBI is revealed to be superior to WLI in the detection and differential diagnosis for superficial head and neck cancer (7).
Watanabe et al. reported that the NBI rhinolaryngoscope (ENF-V2, Olympus Medical Systems) with a color-chip light source (CLV-160B, Olympus Medical Systems) improved the diagnostic accuracy, and the negative predictive values for superficial lesions in the oropharynx and hypopharynx compared with those of conventional WLI (8, 9) . However, there is still a critical difference in the image qualities of CCDs between the gastrointestinal endoscopy and that the rhinolaryngoscope.
Ugumori et al. prospectively compared the images taken with a color-chip-based rhinolaryngoscope and those taken with an RGB-sequential-system-based high-resolution gastrointestinal endoscope (10) . Whereas the conventional white-light rhinolaryngoscope identified well-demarcated line between the neoplastic and nonneoplastic lesions in only 10% (5/51) of cases and microvascular irregularities in only 27% (14/51), the NBI rhinolaryngoscope identified these in 63% (32/51) and 94% (49/51) of cases, respectively. These results indicate that even with a rhinolaryngoscope, NBI can improve the visualization of epithelial neoplasms of the head and neck region.
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When combined with a high-definition television camera (HDTV), the effectiveness of NBI is improved in terms of both its sensitivity and specificity. (11) NBI is also reportedly useful in detecting metachronous SCC after treatment for esophageal SCC (chemoradiotherapy, radiation therapy, or surgery), and unknown primary SCC of the neck, and adenoid hypertrophy (12-18) ( Table 1 ).
The early detection of cancer in this region increases the possibility of minimally invasive surgery, including endoscopic mucosal resection and endoscopic submucosal dissection methods (19, 20) . The potential advantages to patients resulting from an early diagnosis, with the preservation of organ and tissue functions, are obvious.
Esophagus ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Although the early detection of cancer offers the best prognosis, many esophageal SCCs (ESCCs) are still detected at a late stage, with a consequently poor prognosis. One reason is that the early detection of ESCC is difficult using conventional WLI endoscopy because it cannot identify the morphological changes of superficial ESCC.
Although Lugol chromoendoscopy is the sanistive method for the detection of early (23). The sensitivity of NBI was significantly better than that of conventional WLI. The specificity and positive predictive value of NBI were also better than those of Lugol chromoendoscopy, whereas their diagnostic accuracy and negative predictive value were similar. These results suggest that, even when an ultrathin endoscope is used, NBI is the best tool for screening for superficial esophageal neoplasms, as in the head and neck region.
In a multicenter prospective randomized study (7), NBI with a standard-diameter endoscope showed approximately twofold greater sensitivity than WLI. Furthermore, most of the Lugol-voiding lesions overlooked by NBI endoscopy were low grade intraepithelial neoplasia or lesions without atypical findings (24) .
In 2011, a new classification of magnified endoscopy for superficial ESCC was 8 proposed by Japan Esophageal Society (2d5), which allows the differential diagnosis of ESCC, intraepithelial neoplasia, and inflammation. This classification is expected to simplify the diagnosis and evaluation of the depth of invasion of superficial ESCCs.
GASTROESOPHAGEAL REFLUX DISEASE (GERD)
GERD is defined by the presence of reflux esophagitis. When it causes reflux symptoms (chest pain, heartburn, discomfort, etc.), the patient's quality of life is adversely affected (26) . Moreover, a significant number of patients with GERD symptoms show no endoscopic signs of esophagitis. This condition is described as "nonerosive reflux disease" (NERD). Many NERD patients show minimal endoscopic findings, such as a whitish or reddish edematous change or erosion that is not regarded as a mucosal break (27) . These minimal changes are potentially related to various GERD symptoms (28) . However, the interobserver agreement when NERD is diagnosed with conventional WLI is reportedly too low to support the clinical significance of this technique (29) . In contrast, NBI is expected to overcome this limitation, because it allows the visualization of the superficial and slight findings attributable to NERD, which cannot be seen with conventional WLI.
Lee et al. reported that the intraobserver and interobserver consistencies in grading 9 esophagitis improved when NBI was used instead of WLI (30). Sharma et al. reported a feasibility study of magnified endoscopy with NBI in patients with GERD (31). They showed that increased numbers and the dilatation of IPCLs were the best predictors of a diagnosis of GERD, with moderate to high interobserver agreement.
BARRETT'S ESOPHAGUS AND CANCER
The incidence of esophageal adenocarcinoma is increasing in Western countries (32) and Barrett's esophagus (BE) is a precursor lesion of this malignancy. Surveillance of BE using WLI with random four-quadrant biopsies is the accepted practice and is recommended by the American Gastroenterological Association statement (33). Sharma et al. (34) showed in a randomized, controlled, international, crossover trial that the success of NBI in detecting intestinal metaplasia did not differ from that of the currently accepted practice of random biopsies, but required significantly fewer biopsies.
Because esophageal adenocarcinoma has a poor prognosis when detected at an advanced stage, endoscopic surveillance is recommended to detect high-grade dysplasia and mucosal neoplasia in patients with BE. However, it is difficult to identify these lesions with conventional WLI. NBI with magnifying endoscopy allows us to visualize the details of the mucosal microsurface pattern and the microvascular pattern without additional equipment or dye solutions (35).
Hamamoto et al. first reported that NBI could better visualize the esophagogastric junction, net-like capillary vessels, and columnar-lined esophagus (seen in BE) than conventional WLI (36). Kara et al. reported that indigo carmine chromoendoscopy and NBI were similarly effective in the diagnosis of high-grade dysplasia or early cancer in BE (37). Wolfsen et al. (38) reported that high-resolution NBI can detect dysplastic lesions more efficiently, with fewer biopsy samples, than standard-resolution WLI.
Singh et al. (39) reported that NBI with magnification is superior to WLI with magnification in the prediction of histology in BE.
A recent meta-analysis (40) that included 446 patients with 2194 lesions reported that NBI with magnification shows high diagnostic precision in detecting high-grade dysplasia, with a sensitivity and specificity of 96% and 94%, respectively.
Stomach DETECTION OF GASTRIC NEOPLASM BY NBI
In the stomach, NBI has been considered to be used with magnification for detailed examinations. Because the light intensity under the NBI filter is low, a non-magnified image becomes dark compared with that produced under WLI. Furthermore, because 11 the image becomes noisy with the electrical enhancement used to keep the endoscopic image bright, it is insufficient to observe the wide area of the stomach. There is also, as yet, no evidence that NBI is superior to WLI in detecting early gastric neoplasms. To overcome these limitations, much brighter NBI system with higher resolution will be commercially available when this review is published. Then, the evidence of other clinical benefit of NBI such as detection will be expected in future. These lines of evidence suggest that magnifying NBI is currently one of the standard endoscopic modalities in the differential diagnosis of gastric cancers.
DIFFERENTIAL DIAGNOSIS OF GASTRIC CANCER
DETERMINATION OF THE LATERAL EXTENT OF GASTRIC CANCER
To achieve the complete resection of a mucosal gastric cancer with endoscopic resection, an accurate diagnosis of the extent of the tumor is required. By clearly visualizing the microvascular architecture and the microsurface structure inside and outside the lesion, magnifying NBI can distinguish the cancer margins from the surrounding benign mucosa, so it is expected to be useful for delineating the extent of a gastric tumor. In cancer. These lines of evidence suggest that magnifying NBI can be a useful modality for determining the lateral extent of gastric cancer. However, it must be emphasized that it is still difficult to accurately define the tumor margin in undifferentiated gastric cancers; the successful delineation rate was 0% for undifferentiated cancers in one study (50) . Because undifferentiated gastric cancers often spread subepithelially and are covered with nonneoplastic foveolar epithelium, observation of the mucosal surface by NBI is not useful for determining the tumor margin of this type of gastric cancer. Therefore, it is necessary to take biopsy specimens of the surrounding mucosa to define the extent of an otherwise undetectable tumor in undifferentiated gastric cancers.
PREDICTION OF THE HISTOLOGICAL TYPE OF GASTRIC CANCER
Nakayoshi et al. reported that the different microvascular patterns detected with magnifying NBI images are useful in predicting the histological type of a superficial 14 gastric cancer (51) . Differentiated adenocarcinomas display a "fine network pattern," and undifferentiated adenocarcinomas display a "corkscrew pattern" in their microvascular structures (Figure 2) . Yoshida et al. reported that a "nonstructural pattern" appeared to be a useful marker of undifferentiated superficial gastric cancers (52) .
Although these studies have indicated the utility of magnifying NBI in the prediction of the histopathological type of a gastric cancer, its reliability must be validated in a large-scale prospective study. Moreover, even if magnifying NBI can predict the histological type of a cancerous lesion, histological confirmation by biopsy is required at this time. However, the prediction of histological type could be useful to the endoscopists when selecting the site of a biopsy in a lesion because gastric cancers are usually heterogeneous.
DIAGNOSIS OF THE TUMOR DEPTH OF GASTRIC CANCER
In contrast to ESCC, there is no evidence that NBI, with or without magnifying endoscopy, can predict the depth of tumor invasion in a patient with gastric cancer.
DIAGNOSIS OF GASTRIC ADENOMA
Because most gastric adenomas form protruded lesions, the differential diagnosis of protruded gastric cancer and protruded adenoma is sometimes difficult (53, 54) 
